101 related articles for article (PubMed ID: 24392554)
1. The interobserver reproducibility of thyroid cytopathology using Bethesda Reporting System: analysis of 200 cases.
Ahmed S; Ahmad M; Khan MA; Kazi F; Noreen F; Nawaz S; Sohail I
J Pak Med Assoc; 2013 Oct; 63(10):1252-5. PubMed ID: 24392554
[TBL] [Abstract][Full Text] [Related]
2. A histological assessment of the Bethesda system for reporting thyroid cytopathology (2010) abnormal categories: a series of 219 consecutive cases.
Tepeoğlu M; Bilezikçi B; Bayraktar SG
Cytopathology; 2014 Feb; 25(1):39-44. PubMed ID: 23438201
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the bethesda system for reporting thyroid cytopathology and similar precursor thyroid cytopathology reporting schemes.
Wong LQ; Baloch ZW
Adv Anat Pathol; 2012 Sep; 19(5):313-9. PubMed ID: 22885380
[TBL] [Abstract][Full Text] [Related]
4. Correlation of thyroid fine-needle aspiration with final histopathology: a case series.
Gürkan Dumlu E; Kiyak G; Bozkurt B; Tokaç M; Polat B; Cakir B; Güler G; Kiliç M
Minerva Chir; 2013 Apr; 68(2):191-7. PubMed ID: 23612233
[TBL] [Abstract][Full Text] [Related]
5. A simplified Bethesda System for reporting thyroid cytopathology using only four categories improves intra- and inter-observer diagnostic agreement and provides non-overlapping estimates of malignancy risks.
Walts AE; Bose S; Fan X; Frishberg D; Scharre K; de Peralta-Venturina M; Zhai J; Marchevsky AM
Diagn Cytopathol; 2012 May; 40 Suppl 1():E62-8. PubMed ID: 21557534
[TBL] [Abstract][Full Text] [Related]
6. Hürthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology.
Yazgan A; Balci S; Dincer N; Kiyak G; Tuzun D; Ersoy R; Cakir B; Guler G
Cytopathology; 2014 Jun; 25(3):185-9. PubMed ID: 24024935
[TBL] [Abstract][Full Text] [Related]
7. Implementation of the bethesda system for reporting thyroid cytopathology: interobserver concordance and reclassification of previously inconclusive aspirates.
Pathak P; Srivastava R; Singh N; Arora VK; Bhatia A
Diagn Cytopathol; 2014 Nov; 42(11):944-9. PubMed ID: 24692395
[TBL] [Abstract][Full Text] [Related]
8. Follicular lesion of undetermined significance in thyroid FNA revisited.
Walts AE; Mirocha J; Bose S
Diagn Cytopathol; 2014 Jan; 42(1):18-22. PubMed ID: 23894017
[TBL] [Abstract][Full Text] [Related]
9. Malignancy risk and reproducibility associated with atypia of undetermined significance on thyroid cytology.
Mathur A; Najafian A; Schneider EB; Zeiger MA; Olson MT
Surgery; 2014 Dec; 156(6):1471-6; discussion1476. PubMed ID: 25218896
[TBL] [Abstract][Full Text] [Related]
10. Yield of repeat fine-needle aspiration biopsy and rate of malignancy in patients with atypia or follicular lesion of undetermined significance: the impact of the Bethesda System for Reporting Thyroid Cytopathology.
Chen JC; Pace SC; Chen BA; Khiyami A; McHenry CR
Surgery; 2012 Dec; 152(6):1037-44. PubMed ID: 23040711
[TBL] [Abstract][Full Text] [Related]
11. The prediction of malignant risk in the category "atypia of undetermined significance/follicular lesion of undetermined significance" of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results.
Hyeon J; Ahn S; Shin JH; Oh YL
Cancer Cytopathol; 2014 May; 122(5):368-76. PubMed ID: 24591408
[TBL] [Abstract][Full Text] [Related]
12. The Bethesda System for Reporting Thyroid Fine-Needle Aspiration Cytology: A Kuwaiti Experience - A Cytohistopathological Study of 374 Cases.
Kapila K; Qadan L; Ali RH; Jaragh M; George SS; Haji BE
Acta Cytol; 2015; 59(2):133-8. PubMed ID: 25676743
[TBL] [Abstract][Full Text] [Related]
13. Role of fine-needle aspiration in the management of thyroid nodules.
Mofid AR; Yazdani T; Shahrzad M; Seyedalinaghi S; Zandieh S
Saudi Med J; 2009 Apr; 30(4):515-8. PubMed ID: 19370278
[TBL] [Abstract][Full Text] [Related]
14. The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System.
Sullivan PS; Hirschowitz SL; Fung PC; Apple SK
Cancer Cytopathol; 2014 Dec; 122(12):866-72. PubMed ID: 25078420
[TBL] [Abstract][Full Text] [Related]
15. Assessment of cytotechnologist-cytopathologist interpretative agreement using the Bethesda system for reporting thyroid cytopathology.
Lokhandwala PM; Abendroth CS; Wang M; Mani H; Williams NC; Walls M; Zander DS
Diagn Cytopathol; 2016 Feb; 44(2):113-8. PubMed ID: 26663577
[TBL] [Abstract][Full Text] [Related]
16. The Bethesda terminology for reporting thyroid cytopathology: from theory to practice in Europe.
Cochand-Priollet B; Schmitt FC; Tötsch M; Vielh P;
Acta Cytol; 2011; 55(6):507-11. PubMed ID: 22156458
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of liquid-based (Liqui-PREP) preparations and interobserver reproducibility in fine needle aspiration cytology of the nodular thyroid lesions.
Tetikkurt US; Oz Puyan F; Oz F; Erdogan N; Ceylan S; Yakupoglu A
Diagn Cytopathol; 2012 May; 40(5):388-93. PubMed ID: 21538948
[TBL] [Abstract][Full Text] [Related]
18. Fine needle aspiration of thyroid: a cyto-histopathological correlation in Ramathibodi Hospital.
Himakhun W; Chansom R; Aroonroch R; Pongtippan A
J Med Assoc Thai; 2012 Jan; 95 Suppl 1():S74-8. PubMed ID: 23964447
[TBL] [Abstract][Full Text] [Related]
19. The interobserver reproducibility of thyroid fine-needle aspiration using the UK Royal College of Pathologists' classification system.
Kocjan G; Chandra A; Cross PA; Giles T; Johnson SJ; Stephenson TJ; Roughton M; Poller DN
Am J Clin Pathol; 2011 Jun; 135(6):852-9. PubMed ID: 21571958
[TBL] [Abstract][Full Text] [Related]
20. Spectrum of risk of malignancy in subcategories of 'atypia of undetermined significance'.
Olson MT; Clark DP; Erozan YS; Ali SZ
Acta Cytol; 2011; 55(6):518-25. PubMed ID: 22156460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
